Quest Diagnostics Incorporated
DGX
Rank in Stocks
#928
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Share Price
$234.81
Last synced: 2026-10-19
Market Cap
$25.92B
Change (1 day)
0.04%
Change (1 year)
23.32%
Country
US
Trade Quest Diagnostics Incorporated (DGX)
Category
Healthcare
Earnings for Quest Diagnostics Incorporated (DGX)
Earnings in Jun 2026 TTM: $1.42B
According to Quest Diagnostics Incorporated latest financial reports the company's current earnings are $1.42B. In 2024 the company made an earning of $1.19B, an increase over its 2023 earnings that were of $1.16B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Quest Diagnostics Incorporated from 2000 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $1.42B | 4.34% |
| 2025 | $1.36B | 13.90% |
| 2024 | $1.19B | 3.29% |
| 2023 | $1.16B | -9.62% |
| 2022 | $1.28B | -52.22% |
| 2021 | $2.68B | 36.65% |
| 2020 | $1.96B | 72.90% |
| 2019 | $1.13B | 22.35% |
| 2018 | $926.00M | -10.10% |
| 2017 | $1.03B | -5.16% |
| 2016 | $1.09B | -1.54% |
| 2015 | $1.10B | 29.92% |
| 2014 | $849.00M | -37.02% |
| 2013 | $1.35B | 26.17% |
| 2012 | $1.07B | 24.77% |
| 2011 | $856.30M | -27.70% |
| 2010 | $1.18B | -3.55% |
| 2009 | $1.23B | 20.50% |
| 2008 | $1.02B | 11.68% |
| 2007 | $912.40M | -11.70% |
| 2006 | $1.03B | 13.49% |
| 2005 | $910.45M | 9.02% |
| 2004 | $835.13M | 13.19% |
| 2003 | $737.80M | 36.03% |
| 2002 | $542.38M | 63.07% |
| 2001 | $332.60M | 65.49% |
| 2000 | $200.98M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $7.61B | 436.22% |
US
|
|
| $4.76B | 235.59% |
US
|
|
| $-252.70M | -117.81% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 16.84% |
US
|
